---
$id: https://graph.org.ai/products/commodity/51152052
$type: Product
source: UNSPSC
code: "51152052"
title: "Cyclobenzaprine hydrochloride"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyclobenzaprine hydrochloride

**UNSPSC Code**: 51152052
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant and antidepressant agent with the molecular formula C20H21N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0VE05JYS2P, chemically known as 10,11-dehydroamitriptyline but more generally known as cyclobenzaprine hydrochloride, which bears US NIH Compound Identifier 2895. European Medicines Agency schedules Cyclobenzaprine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13514MIG. Most nations, for tariff and trade purposes, schedule cyclobenzaprine hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, CYCLOBENZAPRINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cyclobenzaprine hydrochloride bears US NLM identifiers UMLS ID C0125988 and NCI Concept Code C47465. SMILES: CN(C)CCC=C1C2CCCCC2C=CC3C1CCCC3.CL.

